Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 200 of 464 entries
View as:

Pemetrexed in Patients With Soft Tissue Sarcoma

Phase: N/A Priority: Normal
NCT ID: NCT00427466 Org: User:
Start: 01/31/07 End: 12/31/08 Due: 12/31/09

Kids Obesity Prevention Program - Study (KOP)

Phase: N/A Priority: Normal
NCT ID: NCT02551978 Org: User:
Start: 09/30/15 End: 11/30/15 Due: 11/30/16

Improving Insulin Sensitivity by Non-invasive Brain Stimulation in Persons With Insulin Resistance

Phase: N/A Priority: Normal
NCT ID: NCT04052399 Org: User:
Start: 11/04/19 End: 12/31/21 Due: 12/31/22

Nutritional Prevention of Diabetes Mellitus Type 2

Phase: N/A Priority: Normal
NCT ID: NCT03231839 Org: User:
Start: 02/01/09 End: 07/31/16 Due: 07/31/17

Prolactin Release Through Breast Stimulation in Non-lactating Women - Who Does Respond?

Phase: N/A Priority: Normal
NCT ID: NCT05208684 Org: User:
Start: 02/21/22 End: 12/31/24 Due: 12/31/25

Glucose Tolerance in Acromegaly: The Influence of GH-excess on Glucose Metabolism and Insulin Resistance

Phase: N/A Priority: Normal
NCT ID: NCT00663000 Org: User:
Start: 04/30/08 End: 12/31/12 Due: 12/31/13

Long-term Bilateral Theta Burst Stimulation for the Treatment of Major Depression

Phase: N/A Priority: Normal
NCT ID: NCT01153139 Org: User:
Start: 04/30/10 End: 07/31/13 Due: 07/31/14

Exercise Training in Patients With Cardioverter-Defibrillators

Phase: N/A Priority: Normal
NCT ID: NCT00754663 Org: User:
Start: 05/31/08 End: 11/30/09 Due: 11/30/10

Central Insulin Sensitivity in Individuals With Type 2 Diabetes (T2D) and at Risk for Developing T2D

Phase: N/A Priority: Normal
NCT ID: NCT05856877 Org: User:
Start: 05/26/23 End: 12/31/25 Due: 12/31/26

Amplification and Selection of Antimicrobial Resistance in the Intestine

Phase: N/A Priority: Normal
NCT ID: NCT02058888 Org: User:
Start: 01/31/15 End: 05/31/17 Due: 05/31/18

Bloodstream Infection Due to Multidrug-Resistant Organisms - Multicenter Study on Determinants of Clinical Outcomes

Phase: N/A Priority: Normal
NCT ID: NCT03578835 Org: User:
Start: 02/01/17 End: 06/30/19 Due: 06/30/20

Effects of Ghrelin Administration on Dopamine and Effort

Phase: N/A Priority: Normal
NCT ID: NCT05318924 Org: User:
Start: 02/21/22 End: 10/31/24 Due: 10/31/25

Dapagliflozin Effect on Erythropoiesis and Physical Fitness

Phase: N/A Priority: Normal
NCT ID: NCT03423355 Org: User:
Start: 09/30/21 End: 12/31/23 Due: 12/31/24

Characterization of Metabolic and Brain Effects of Rising Glucagon During an Oral Glucose Challenge

Phase: N/A Priority: Normal
NCT ID: NCT03061227 Org: User:
Start: 02/10/17 End: 04/30/20 Due: 04/30/21

Pathophysiology Based Therapy of Early Onset Epileptic Encephalopathies

Phase: N/A Priority: Normal
NCT ID: NCT02968966 Org: User:
Start: 12/01/18 End: 08/31/20 Due: 08/31/21

The Effect of Two Different Non-pharmacologic Methods for Painandfear Relief During Blood Specimen Collection Inchildren

Phase: N/A Priority: Normal
NCT ID: NCT05560074 Org: User:
Start: 08/04/22 End: 11/30/22 Due: 11/30/23

Influence of Hypoxia on Electroretingraphy (ERG) Measurements

Phase: N/A Priority: Normal
NCT ID: NCT01246024 Org: User:
Start: 02/28/11 End: 04/30/13 Due: 04/30/14

First-in-man Single-dose and Multiple Dose Study to Evaluate the Safety, Tolerability and Efficacy ofHY-133

Phase: N/A Priority: Normal
NCT ID: NCT06290557 Org: User:
Start: 07/10/24 End: 07/01/26 Due: 07/01/27

Fatty Acid Composition of Subcutaneous Adipose Tissue in Infants: A Prospective and Observational Study

Phase: N/A Priority: Normal
NCT ID: NCT03785990 Org: User:
Start: 04/03/17 End: 10/31/19 Due: 10/31/20

Insulin Sensitivity of the Human CNS System: fMRI Study With Intranasal Insulin Application

Phase: N/A Priority: Normal
NCT ID: NCT01797601 Org: User:
Start: 02/28/13 End: 04/30/14 Due: 04/30/15

DigiPuR: Digitally Supported Psychotherapy and Reintegration

Phase: N/A Priority: Normal
NCT ID: NCT04986228 Org: User:
Start: 11/01/21 End: 07/31/23 Due: 07/31/24

Neurophysiological Correlates of Exposition Therapy in Spider Phobia

Phase: N/A Priority: Normal
NCT ID: NCT03653923 Org: User:
Start: 10/31/18 End: 01/31/20 Due: 01/31/21

Trial for Localised High-risk Rhabdomyosarcoma and Rhabdomyosarcoma-like Soft Tissue Sarcoma

Phase: N/A Priority: Normal
NCT ID: NCT00876031 Org: User:
Start: 07/01/09 End: 06/30/22 Due: 06/30/23

Amplification and Selection of Antimicrobial Resistance in the Intestine II

Phase: N/A Priority: Normal
NCT ID: NCT03140826 Org: User:
Start: 01/30/18 End: 07/31/20 Due: 07/31/21

Comparison of a Smartphone Based Self Refraction Tool With Conventional Refraction Error Estimation Methods

Phase: N/A Priority: Normal
NCT ID: NCT03419351 Org: User:
Start: 11/20/17 End: 03/31/18 Due: 03/31/19